Australia - English - Department of Health (Therapeutic Goods Administration)

hirlhead pty ltd t/a aps medical - 16649 - intravenous administration set, general-purpose - tube set with accessories used to convey fluid from a reservoir to an infusion point.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

18-21mmhg) tights closed toe lymphoedema garment petite size vi black (bsn medical ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 35041 - adaptor, cable, electrosurgical unit - an adaptor cable to connect an rf electrode to an electrosurgical unit.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - ciclesonide (unii: s59502j185) (ciclesonide - unii:s59502j185) - ciclesonide 80 ug - alvesco is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. alvesco is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. alvesco is contraindicated in patients with known hypersensitivity to ciclesonide or any of the ingredients of alvesco. rare cases of hypersensitivity reactions with manifestations such as angioedema, with swelling of the lips, tongue and pharynx, have been reported. teratogenic effects : pregnancy category c oral administration of ciclesonide in rats up to 900 mcg/kg/day (approximately 10 times the maximum human daily inhalation dose based on mcg/m2 /day) produced no teratogenicity or other fetal effects. however, subcutaneous administration of ciclesonide in rabbits at 5 mcg/kg/day (less than the maximum human daily inhalation dose based on mcg/m2 /day) or greater produced fetal toxicity. this included fetal loss, reduc

United States - English - NLM (National Library of Medicine)

wal-mart stores, inc. - ensulizole (unii: 9yq9di1w42) (ensulizole - unii:9yq9di1w42), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - ensulizole 1.7 g in 100 g - sunscreen - helps prevent sunburn

United States - English - NLM (National Library of Medicine)

bionpharma inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: -  glimepiride or any of the product’s ingredients [see warnings and precautions (5.2)]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g., anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse rea

United States - English - NLM (National Library of Medicine)

target corp - triclosan (unii: 4nm5039y5x) (triclosan - unii:4nm5039y5x) - antibacterial for handwashing to decrease bacteria on the skin irritation or redness develops

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

5003) (34-46mmhg) thigh length closed toe with silicone top band lymphoedema garment female large black (credenhill ltd -

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - malaria hydroxychloroquine sulfate is indicated for the treatment of uncomplicated malaria due to p. falciparum, p. malariae, p. ovale, and p. vivax. hydroxychloroquine sulfate is indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. limitations of use in malaria - hydroxychloroquine sulfate is not recommended for the treatment of complicated malaria. - hydroxychloroquine sulfate is not effective against chloroquine or hydroxychloroquine-resistant strains of plasmodium species (see clinical pharmacology - microbiology). hydroxychloroquine sulfate is not recommended for the treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the plasmodium species has not been identified. - hydroxychloroquine sulfate is not recommended for malaria prophylaxis in geographic areas where chloroquine resistance occurs. - hydroxychloroquine sulfate does not prevent relapses of p. vivax or p. ovale because it is not active against the

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

gp grenzach produktions gmbh - dexpanthenol - ointment - 50mg/g